Human Mesenchymal Stromal Cells Broadly Modulate High Glucose-induced Inflammatory Responses of Renal Proximal Tubular Cell Monolayers
Overview
Authors
Affiliations
Background: Renal proximal tubular epithelial cells (RPTEC) are dysfunctional in diabetic kidney disease (DKD). Mesenchymal stromal cells (MSC) may modulate DKD pathogenesis through anti-inflammatory mediators. This study aimed to investigate the pro-inflammatory effect of extended exposure to high glucose (HG) concentration on stable RPTEC monolayers and the influence of MSC on this response.
Methods: Morphologically stable human RPTEC/TERT1 cell monolayers were exposed to 5 mM and 30 mM (HG) D-glucose or to 5 mM D-glucose + 25 mM D-mannitol (MAN) for 5 days with sequential immunoassays of supernatants and end-point transcriptomic analysis by RNA sequencing. Under the same conditions, MSC-conditioned media (MSC-CM) or MSC-containing transwells were added for days 4-5. Effects of CM from HG- and MAN-exposed RPTEC/MSC co-cultures on cytokine secretion by monocyte-derived macrophages were determined.
Results: After 72-80 h, HG resulted in increased RPTEC/TERT1 release of interleukin (IL)-6, IL-8, monocyte chemoattractant protein (MCP)-1 and neutrophil gelatinase-associated lipocalin (NGAL). The HG pro-inflammatory effect was attenuated by concentrated (10×) MSC-CM and, to a greater extent, by MSC transwell co-culture. Bioinformatics analysis of RNA sequencing data confirmed a predominant effect of HG on inflammation-related mediators and biological processes/KEGG pathways in RPTEC/TERT1 stable monolayers as well as the non-contact-dependent anti-inflammatory effect of MSC. Finally, CM from HG-exposed RPTEC/MSC transwell co-cultures was associated with attenuated secretion of inflammatory mediators by macrophages compared to CM from HG-stimulated RPTEC alone.
Conclusions: Stable RPTEC monolayers demonstrate delayed pro-inflammatory response to HG that is attenuated by close proximity to human MSC. In DKD, this MSC effect has potential to modulate hyperglycemia-associated RPTEC/macrophage cross-talk.
Jin C, Wu P, Wu W, Chen W, Liu W, Zhu Y Cell Biol Toxicol. 2025; 41(1):50.
PMID: 39992453 PMC: 11850457. DOI: 10.1007/s10565-025-09998-2.
Liu J, Li Z, Zhang Z, Shen Z Sci Rep. 2025; 15(1):6503.
PMID: 39987179 PMC: 11846948. DOI: 10.1038/s41598-025-91264-w.
Sakolish C, Moyer H, Tsai H, Ford L, Dickey A, Bajaj P Drug Metab Dispos. 2025; 53(1):100001.
PMID: 39884810 PMC: 11822869. DOI: 10.1124/dmd.124.001488.
Kyun M, Park T, Jung H, Kim I, Kwon J, Jeong S Tissue Eng Regen Med. 2023; 20(7):1173-1190.
PMID: 37843784 PMC: 10645777. DOI: 10.1007/s13770-023-00602-4.
Wang Y, Jin M, Cheng C, Li Q Front Endocrinol (Lausanne). 2023; 14:1238927.
PMID: 37600689 PMC: 10433744. DOI: 10.3389/fendo.2023.1238927.